Neutralizing monoclonal antibodies raised against intact foot-and-mouth disease virus type O1 reacted with intact virus and trypsin-treated virus particles. Some of the monoclonal antibodies showed a slight but definite reaction with the 12S subunit, but none of them reacted with the isolated capsid protein VP1 or any of the other viral proteins. These results confirm the difference between the neutralizing antigenic determinants exposed on intact virus particle and on isolated capsid protein VP1. They suggest further that the neutralizing antigenic determinant and the cell attachment site are not identical.
Short communication
FMDV type O, subtype 1, strain BFS 1860 grown in BHK suspension cell culture was used. Purification, trypsin treatment and 12S preparation were done as described by Meloen & Briaire (1980) . Antisera were raised in rabbits against 140S virion and against isolated VP1 in the presence of 0.1 ~o SDS as described previously (Meloen & Briaire, 1980) . Monoclonal antibodies were prepared against purified 140S according to the method described by Fazekas & Scheidegger (1980) with some modifications. BALB/c mice, at least 2 months of age, were immunized by intraperitoneal injection of 100 ~tg of inactivated purified 140S, adsorbed onto 0-1 ml aluminium hydroxide. After approximately 3 months, a seropositive mouse was injected intraperitoneally with 100 ~tg of 140S in 0.1 ml buffered saline and the next day intra-orbitally with the same dose of antigen. The spleen was removed for fusion 3 days after the last injection. Spleen cells (7 × 107) were fused with 5 x 107 myeloma cells of the line X63-Ag8.653 (Kearney et al., 1979) using in all fusion steps Eagle's minimal essential medium for suspension cultures, with 0.01 EDTA (A. D. Osterhaus, personal communication). Thus, a calcium-free medium was used, which might decrease the possible toxicity of polyethylene glycol in mammalian cell hybridization (Schneiderman et aL, 1979) . After fusion, 75~ of the cells were distributed over eight 24-well hybridoma plates (Greiner) and the remainder over three 96-well microtitre plates (Costar), both with macrophages as feeder cells. Thus, the cells were grown at two cell densities. Growing colonies were observed in all wells. At 10 days after fusion, supernatants from all wells were found to be positive in an enzyme-linked immunosorbent assay (ELISA), indicating a very high frequency of positive clones. Thirty-nine colonies producing neutralizing antibodies were selected by a microneutralization test (MNT). Neutralizing and non-neutralizing colonies were cloned twice by limiting dilution. Finally, 13 neutralizing clones were obtained. Monoclonal antibodies were produced by injecting Pristane-treated BALB/c mice intraperitoneally with 1 × 106 to 2 x 106 cells. Ascites fluid was collected repeatedly after approximately 1 week and was stored at -20 °C.
The MNT, radioimmunoassay (RIA) and ELISA were essentially the same as those applied previously (Meloen & Briaire, 1980) . In the RIA, [35S]methionine-labelled 140S, 140S tryp and 12S were used; isolated VP1 was prepared as described by Meloen & Briaire (1980) and labelled with ~2sI according to the iodogen method (Fraker & Speck, 1978) . When VP1 was used in the ELISA, plates were coated with isolated VP1 in the presence of 0.01 ~o SDS.
Western blotting was performed with monoclonal antibodies, anti-VP1 sera and disrupted 140S as described previously (Towbin et al., 1979; Bittle et al., 1982) ; the immunodiffusion (ID) test has been described by Meloen (1981) , with the exception that the anti-antibody preparation was conjugated to horseradish peroxidase. Its presence was visualized by reaction with 3,3'-diaminobenzidine tetrahydrochloride.
Thirteen neutralizing and two non-neutralizing monoclonal antibody preparations were selected for this study. They were tested in the MNT, RIA and ELISA: in the RIA against 140S, 140S tryp and VP1 ; in the ELISA against 140S, 12S and VP1. For comparison, antisera against VP1 and 140S were sometimes included in the tests. The results are shown in Table 1 .
The neutralizing activity of some of the monoclonal antibody preparations was almost 100-fold higher than is normally obtained by hyperimmunization. The same applied to the activities measured in the ID, RIA and ELISA with 140S. Monoclonal antibodies did not react in the RIA with 12S or isolated VP1, whereas some gave a weak reaction with 12S in the ELISA. The difference may be explained by the fact that in the RIA the 12S particles were suspended in solution, while in the ELISA they were coated onto the polystyrene surface which may alter their conformation. No reaction was seen with isolated VP1 in RIA or ELISA tests. In addition, monoclonal antibodies 2, 8 and 11 were tested by Western blotting. None of them reacted, even at low dilution, with the separated viral proteins. In contrast, anti-VP1 serum produced a strong reaction. The results for monoclonal antibody 11 are shown in Fig. 1 .
All monoclonal antibodies reacted with I40S tryp and showed the expected confluent lines when tested against 140S and 140S tryp in ID tests. A typical result is shown in Fig. 2 .
In this study, we have shown that neutralizing monoclonal antibodies do not react with VP1 and only some, with a low titre, with 12S. They do, however, react with 140S tryp (Table 1 ). This latter reaction, and the observed absence of exposure of VP2 and VP3 (Meloen, 1981) , show that the antigenicity of 140S tryp is closely related to that of D antigenic particles. These data suggest that the cell attachment site that is sensitive to trypsin treatment (Rowlands et al., 1975) is not identical with the main neutralizing determinant. Data obtained in our~laboratory with the same strain of virus show that after trypsinization the drop in infectivity, as measured in a plaque test, is associated with a somewhat less dramatic drop in immunogenicity, as measured in a guineapig protection test (S. J. Barteling, personal communication). This may Suggest that the cell attachment site is located near the main antigenic determinant which is only slightly affected by trypsin. A similar situation has been observed for influenza virus A (Wiley et al., 1981) , where the cell attachment site is also located near the main neutralizing sites. The majority of the neutralizing monoclonal antibodies react equally well with 140S and 140S tryp; however, antibodies 1, 5 and 15 react less well with 140S tryp (Table 1) . These might therefore be directed to that part of the main antigenic determinant which borders on the cell attachment site, if one assumes, as is done in this study, that FMDV possesses only one main neutralizing determinant. The two non-neutralizing monoclonal preparations do not seem to be directed to either the main antigenic determinant or the cell attachment site.
Bittle et al. (1982) described a synthetic peptide which ha s the sequence of the region of VP1 between amino acids 141 and 160 and which is able to raise neutralizing activity and induce protection. Antisera to this peptide react poorly or not at all with VP1 by Western blotting. In contrast, peptide 200-213 produces only poor protection and neutralizing activity, However, the anti-peptide 200-213 sera react well with VP 1 in the blotting test. Results similar to these latter ones were obtained with anti-VP1 sera in our laboratory. Furthermore, monoclonal antibodies did not react in the RIA, ELISA or Western blot with VP 1. The blotting technique also yielded only negative reactions with the other viral proteins. This supports the theory of Bittle et al. (1982) that the main neutralizing antigenic determinant is buried, by altered folding, inside isolated VP 1, while a secondary determinant remains exposed. This second determinant could be located at the C-terminus of VPl as this part of the protein is trypsin-sensitive (Strohmaier et This study emphasizes again that the unsatisfactory results obtained with vaccines in which VP1 from either 'native' or 'recombinant' sources are used may be due to the inaccessibility of the main neutralizing determinant on isolated VP1.
